Pharmaconsulta Ltd.

Pharmaconsulta Ltd., established in 2009 by Mr. Andrew Corrieri, is a Malta-based independent consultancy firm specializing in pharmaceutical regulatory affairs for both EU and international markets. The firm offers a comprehensive suite of services, including consultancy, contract manufacturing, laboratory analysis, and Qualified Person (QP) batch release through certified GMP-audited partners. Their experienced team of pharmacists, pharmacologists, and medical doctors provides regulatory support to international pharmaceutical companies and local distributors, assisting with market accession, licensing, pharmacovigilance, Standard Operating Procedure (SOP) development, and strategic planning. With expertise in EU GMP/GDP guidelines, Pharmaconsulta is committed to delivering customized, high-quality regulatory solutions tailored to each client’s unique needs.

The firm's service portfolio encompasses EU market accession, provision of contracted Responsible Person (RP), Qualified Person (QP), and Person Responsible for Quality (PRQ) roles, as well as conducting EU GMP/GDP/GACP audits and licensing. They also offer services related to the Falsified Medicines Directive (FMD) decommissioning of 2D barcodes, medical devices, artificial intelligence projects, pharmacovigilance, laboratory testing, contract manufacturing, clinical trials, logistics consultation and warehousing, and registration of food supplements and cosmetics. This extensive range of services underscores Pharmaconsulta's dedication to supporting clients across various facets of the pharmaceutical industry.

Pharmaconsulta's commitment to integrity and quality is evident in their approach to client service. The team, comprising highly skilled and motivated individuals, collaborates closely with clients to navigate complex regulations and bring trusted solutions to market. Their dedication to excellence and belief that everyone deserves safe and effective healthcare drive their mission to advance health and safety in the pharmaceutical industry. By partnering with clients worldwide, Pharmaconsulta ensures that patient safety and access to high-quality medicines remain at the forefront of their operations.